Darryl J. Sleep

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone‐refractory prostate cancer

Michael A. Carducci, Fred Saad, Per‐Anders Abrahamsson et al. · Cancer · 2007 · 292 citations

Medicine, Oncology, Pharmacology +17

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone‐refractory prostate cancer

Joel B. Nelson, William T. Love, Joseph L. Chin et al. · Cancer · 2008 · 245 citations · Full text

Medicine, Oncology, Pharmacotherapy +6

Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study

Peter H. Jones, Michael H. Davidson, Moti L. Kashyap et al. · Atherosclerosis · 2008 · 91 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients

Eric Q. Wu, Parvez Mulani, Max H. Farrell et al. · Value in Health · 2007 · 85 citations · Full text

Medicine, Oncology, Urology +12

COMBINATION OF SYMPTOM SCORE, FLOW RATE AND PROSTATE VOLUME FOR PREDICTING BLADDER OUTFLOW OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS

Graeme S. Steele, Maryrose P. Sullivan, Darryl J. Sleep et al. · The Journal of Urology · 2000 · 82 citations

Medicine, Urology, Prostate Disease +16